National Blood Authority Annual Report 2023-24
- Total expenses
- $13.3 million
- Ongoing staff
- 76
- Non-ongoing staff
- 2
- Consultancy contracts
- $674,000
- 7 contracts
- Non-consultancy contracts
- $1.85 billion
- 77 contracts
Official source
Published headline figures
Income statement extract
- Total expenses
- $13.3 million (13,297 in $'000)
- Employee benefits
- $8.7 million (8,671 in $'000)
- Suppliers
- $4.6 million (4,626 in $'000)
- Revenue from government
- $8.9 million (8,945 in $'000)
- Own-source income
- $4.3 million (4,299 in $'000)
Unit: Portal template for this table type; the table item itself does not state a unit.
Staff
- Ongoing staff
- 76 people
- Non-ongoing staff
- 2 people
Staff numbers are headcounts as published in the all ongoing and all non-ongoing employee tables, not full-time equivalents.
Consultancy contracts
- Expenditure
- $674,000 (674 in $'000)
- Contracts
- 7
- New contracts
- 4
- Ongoing contracts
- 3
Consultancy contracts table on the Transparency Portal (JSON)
Non-consultancy contracts
- Expenditure
- $1.85 billion (1,853,905 in $'000)
- Contracts
- 77
- New contracts
- 32
- Ongoing contracts
- 45
Non-consultancy contracts table on the Transparency Portal (JSON)
Published disclosure tables 4
Information about remuneration for key management personnel
Source table on the Transparency Portal: Information about remuneration for key management personnel · Licence CC BY 4.0
Key management personnel remuneration is reported on an accrual basis for the period each person held the role, so part-year amounts are not annual salaries.
| Name | Position | Base salary | Bonuses | Other benefits | Superannuation | Long service leave | Other long term | Termination | Total |
|---|---|---|---|---|---|---|---|---|---|
| John Cahill | Chief Executive | 379,942 | 0 | 0 | 37,508 | 8,227 | 0 | 0 | 425,677 |
| Kate McCauley | Deputy Chief Executive | 260,924 | 0 | 0 | 47,333 | 10,519 | 0 | 0 | 318,776 |
| Benjamin Noyen | Deputy Chief Executive from 15 November 2023 | 163,957 | 0 | 0 | 22,769 | 8,308 | 0 | 0 | 195,034 |
| Helen Bull | Deputy Chief Executive 1 July to 14 November 2023 | 65,703 | 0 | 325 | 9,330 | 2,046 | 0 | 0 | 77,404 |
| Elizabeth Quinn | Deputy Chief Executive 1 July to 11 July 2023 | 10,104 | 0 | 0 | 509 | 0 | 0 | 0 | 10,613 |
| Total | Total | 880,630 | 0 | 325 | 117,449 | 29,100 | 0 | 0 | 1,027,504 |
Information about remuneration for senior executives
Source table on the Transparency Portal: Information about remuneration for senior executives · Licence CC BY 4.0
Senior executive and other highly paid staff rows are bands with a count and averages, not individuals. Never multiply or add averages across bands, bodies or years.
| Pay band | People | Average base salary | Average bonuses | Average other benefits | Average superannuation | Average long service leave | Average other long term | Average termination | Average total |
|---|---|---|---|---|---|---|---|---|---|
| 0 - 220000 | 3 | 79,921 | 0 | 108 | 10,869 | 3,451 | 0 | 0 | 94,349 |
| 295001 - 320000 | 1 | 260,924 | 0 | 0 | 47,333 | 10,519 | 0 | 0 | 318,776 |
Organisations Receiving a Share of Reportable Consultancy Contract Expenditure Current Report Period (2023-24)
Source table on the Transparency Portal: Organisations Receiving a Share of Reportable Consultancy Contract Expenditure Current Report Period (2023-24) · Licence CC BY 4.0
| Organisation | Expenditure$'000 GST inclusive |
|---|---|
| Nous Group Pty LtdABN 66086210344 | 334 |
| Gartner Australasia Pty LtdABN 69003708601 | 195 |
| Synergy Group Australia Pty LtdABN 65119369827 | 51 |
| 1 and One Pty LtdABN 13637567947 | 48 |
| HealthConsult Pty LtdABN 67118337821 | 40 |
Organisations Receiving a Share of Reportable Non-Consultancy Contract Expenditure Current Report Period (2023-24)
Source table on the Transparency Portal: Organisations Receiving a Share of Reportable Non-Consultancy Contract Expenditure Current Report Period (2023-24) · Licence CC BY 4.0
| Organisation | Expenditure$'000 GST inclusive |
|---|---|
| Australian Red Cross LifebloodABN 50169561394 | 837,695 |
| CSL Behring (Australia) Pty LtdABN 48160734761 | 690,170 |
| Grifols Australia Pty LtdABN 35050104875 | 112,614 |
| Roche Products Pty LtdABN 70000132865 | 68,995 |
| Octapharma Australia Pty LtdABN 23109574692 | 50,672 |